InvestmentUpdated on 16 December 2025

Fueling the Future of Precision Antimicrobials

CEO at Phagestack GmbH

Pulheim, Germany

About

Phagestack is building an integrated platform for precision antimicrobials, combining proprietary data, AI-driven discovery, experimental validation, and scalable production. By owning the full value chain, we aim to compress development timelines, create multiple revenue streams, and build a defensible position in a rapidly growing global market. We are seeking a lead investor to accelerate scale-up and unlock an existing institutional soft commitment.

Similar opportunities